Why the study?
Does preprocedural platelet-lymphocyte ratio predict no reflow in patients with ST-segment elevation myocardial infarction undergoing primary PCI?
Population
287 patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention
Comparison
Preprocedural platelet-lymphocyte ratio assessment vs Lower vs middle vs higher tertiles of PLR
Design
Cohort
Authors
Loading...
High PLR may identify STEMI patients at elevated no-reflow risk during primary PCI; leaves open incremental value over standard predictors.
Does preprocedural platelet-lymphocyte ratio predict no reflow in patients with ST-segment elevation myocardial infarction undergoing primary PCI?
High preprocedural platelet-lymphocyte ratio and neutrophil-lymphocyte ratio are significant independent predictors of no reflow in STEMI patients undergoing primary PCI.
Yıldız et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: